How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

799 results for

Lidocaine Patch

Latest & greatest

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

261. Depolarising Electrical Skin Stimulation in Neuropathic and Postoperative Pain

stimulation may depolarize unmyelinated skin nociceptors involving NaV1.7 channels. In this case electrical stimulation may provoke pain already with very low currency intensity which normally not provoke pain in healthy subjects. This may be predictive for pain relief due to the sodium channel blocker lidocaine 5% patch. The study will characterize pain states in peripheral neuropathic pain as well as within the painful scar in chronic postoperative pain with regard to the involvement of NaV1.7 channels

2017 Clinical Trials

262. Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors

Simulator Model 600 (Solar Light Co., Inc., Philadelphia, PA) will be used to administer Solar Simulated Light (SSL) exposures to formerly unexposed buttock skin.The device is equipped with six 8mm liquid light guides (LLG), allowing for 6 simultaneously conducted exposures.A large 3x2 endplate places the LLGs several centimeters apart and is specifically designed for Sun Protection Factor (SPF) and photo patch testing. The dose of emission from each LLG can be precisely regulated and the spectrum (...) ) and photo patch testing. The dose of emission from each LLG can be precisely regulated and the spectrum of emission can be limited to UVA (320-390 nm) or UVB+UVA (290-390 nm). The operator can select between UVA only and a combined Ultraviolet-A (UVA)/ Ultraviolet-B (UVB) spectrum by placement of an optical filter. The spectral output (indicated below) follows the distribution of sunlight from 290 to 390 nm. Other Name: Multiport UV Solar Simulator Model 60 No Intervention: ArmC: Without Solar Simulated

2017 Clinical Trials

263. Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics

: Washington University School of Medicine Information provided by (Responsible Party): Washington University School of Medicine Study Details Study Description Go to Brief Summary: During labor and delivery, pregnant women may choose to receive pain relief called epidural analgesia, which is the delivery of a numbing agent through the back and into a body space around the spinal column. This numbs the area of the stomach and the pelvis. Typically the numbing agent is lidocaine, which is a local anesthetic (...) standard care for their headache if they do not have relief from the study procedures. Standard care would be decided by their treating physician and may include oral pain medications and/or medications like ibuprofen [Motrin] or they could have a procedure called an epidural blood patch. This is performed by injecting a small amount of the patient's own blood into the areas of the spinal column where the original epidural anesthesia was injected in order to "patch" the leaks in the dura. Condition

2017 Clinical Trials

264. Efficacy of the Buzzy® Device on the Prevention of Health Care Induced Pediatric Pain in a Vaccination Center

the cooling system. Device: Buzzy® device Just before the vaccination or venipuncture the device will be applied on the selected site during 30 seconds and then it will be moved 5 cm above the selected site to make the injection or the puncture. The child will choose if he wants to use the cooling system. Active Comparator: EMLAPATCH (lidocaine, prilocaine) The patch will be applied during 1 hour to 1 hour and half before the vaccination or venipuncture, on the selected site. After 1 hour to 1 hour (...) and half, it will be removed and the injection or the puncture will be made on the selected site. Drug: EMLAPATCH (lidocaine, prilocaine) The patch will be applied during 1 hour to 1 hour and half before the vaccination or venipuncture, on the selected site. After 1 hour to 1 hour and half, it will be removed and the injection or the puncture will be made on the selected site. Outcome Measures Go to Primary Outcome Measures : Faces Pain Scale revised (FPS-r) for children [ Time Frame: Day 0 ] Pain

2017 Clinical Trials

265. Ipsilateral and contralateral sensory changes in healthy subjects after experimentally induced concomitant sensitization and hypoesthesia. Full Text available with Trip Pro

by quantitative sensory testing (QST) using the protocol of the German Research Network on Neuropathic Pain.Twenty eight healthy subjects were firstly randomized in 2 groups to receive either topical capsaicin (0.6%, 12 cm2, application duration: 15 min.) or a lidocaine/prilocaine patch (25/25 mg, 10 cm2, application duration: 60 min.) on the right volar forearm. Secondly, 7-14 days later in the same area either at first capsaicin (for 15 min.) and immediately afterwards local anesthetics (for 60 min (...) .) was applied (Cap/LA), or in inversed order with the same application duration (LA/Cap). Before, after each application and 7-14 days later a QST was performed bilaterally.Wilcoxon-test, ANOVA, p < 0.05.Single application of 0,6% capsaicin induced thermal hypoesthesia, cold hypoalgesia, heat hyperalgesia and tactile allodynia. Lidocaine/prilocaine alone induced thermal and tactile hypoesthesia as well as mechanical and cold hypoalgesia, and a heat hyperalgesia (to a smaller extent). Ipsilaterally both co

2017 BMC Neurology Controlled trial quality: uncertain

266. Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain

of the first visit and during the study Previous ineffective use of lidocaine patches Morbid obesity Moderate or severe depression An open skin lesion within the painful area where patches will be applied Patients with active or resolved back pain litigation or receiving disability payments due to chronic low back pain Pregnant or breastfeeding females Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study (...) Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain - Full Text View - Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2010 Clinical Trials

267. Contribution of a heating element to topical anesthesia patch efficacy prior to vascular access: results from two randomized, double-blind studies. Full Text available with Trip Pro

Contribution of a heating element to topical anesthesia patch efficacy prior to vascular access: results from two randomized, double-blind studies. Pain associated with superficial procedures, including intravenous (IV) access procedures, should be prevented when possible, especially in children.To evaluate a topical local anesthetic patch containing lidocaine 70 mg/tetracaine 70 mg with a heating element designed to warm the skin and facilitate rapid delivery of local anesthetics into the skin (...) . The pilot study was designed to provide data to inform the design of the definitive study to evaluate the impact of controlled heat on the efficacy of the lidocaine/tetracaine patch (patch) when applied before IV cannulation.Subjects in the pilot study were randomized to eight groups that varied by heated vs. unheated patch, 20 vs. 30 minute application, and 16 vs. 18 G catheter. Subjects in the definitive study were randomized in a double-blind manner to receive either the heated or unheated patch, 20

2010 Journal of pain and symptom management Controlled trial quality: predicted high

268. Preserving Patient Dignity (Formerly: Patient Modesty):Volume 106

are treated with being unnecessarily exposed. Take for instance, for males during a stress test they are told to strip from the waist up and are generally not given a gown like a female patient. They don't leave the room for a male like they would for a female. As a show in taking back his autonomy, my husband refused. He turned around and unbuttoned his shirt, let them place the patches, and rebuttoned his shirt. He unbottoned again for the ultrasound. He did this as a token gesture of control

2019 Bioethics Discussion Blog

269. Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline

in Canada are lidocaine– prilocaine 5% cream or patch (EMLA, AstraZeneca Canada), amethocaine 4% gel (Ametop, Smith and Nephew) and liposo- mal lidocaine 4% cream (Maxilene, RGR Pharma). Education of parents (written, electronic or in person) is required, including specifying the exact site or sites of admin- istration. Topical anesthetics must be applied ahead of time, 20–60 minutes before the injection, depending on the com- mercial product being applied. The topical anesthetic can be applied upon (...) the injection reduce pain at the time of injection? Background and evidence Topical anesthetics reduce pain associated with needle pro - cedures, including venipuncture and intravenous cannula- tion. 57 Our systematic review 12 included 10 trials that evalu- ated the effects of topical anesthetics in a total of 1156 infants and children (up to 15 years of age). 17,58–66 Of the seven studies that compared topical anesthetics with placebo cream or patch, six showed that these drugs were effective in reducing

2011 CPG Infobase

271. Pain (PDQ®): Health Professional Version

. [ ] [ ] Lee JS, Hu HM, Edelman AL, et al.: New Persistent Opioid Use Among Patients With Cancer After Curative-Intent Surgery. J Clin Oncol 35 (36): 4042-4049, 2017. [ ] [ ] Sauerland C, Engelking C, Wickham R, et al.: Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk. Oncol Nurs Forum 33 (6): 1134-41, 2006. [ ] Pucino F, Danielson BD, Carlson JD, et al.: Patient tolerance to intravenous potassium chloride with and without lidocaine. Drug Intell Clin Pharm 22 (9

2016 PDQ - NCI's Comprehensive Cancer Database

272. A mechanistic approach to pain management: Applying the biopsychosocial model to physical therapy

) Terminology. Dec 2017; . [5] Edwards RR, Dworkin RH, Sullivan MD, Turk DC, Wasan AD. The Role of Psychosocial Processes in the Development and Maintenance of Chronic Pain. J. Pain. Sep 2016;17(9 Suppl):T70-92. [6] Demant DT, Lund K, Finnerup NB, et al. Pain relief with lidocaine 5% patch in localized peripheral neuropathic pain in relation to pain phenotype: a randomised, double-blind, and placebo-controlled, phenotype panel study. Pain. Nov 2015;156(11):2234-2244. [7] Sluka KA. Mechanisms and Management

2018 Body in Mind blog

273. A physician’s personal crisis with pain

insurance that covers multiple modalities of therapies. Many insurances are more than happy to cover oxycodone but don’t cover strategies that avoid opioids, such as osteopaths, massage, cold compression machines or even the nerve blocks and lidocaine patches I found to be a lifesaver. In many regions, comprehensive pain centers are either nonexistent or pill mills. People in pain are left see-sawing between over and undertreatment. There is as much a pain crisis in America as an opioid crisis. Chronic

2018 KevinMD blog

274. Herpes simplex - oral

trauma to the area of primary infection, and dental or surgical procedures. Any associated . Any underlying medical conditions that may affect the of herpes simplex infection, such as immunosuppression or atopic eczema. Assess for any red flags that may suggest more serious underlying disease such as oral cancer, including: Unexplained ulceration in the oral cavity lasting for more than 3 weeks. A suspicious lump on the lip or in the oral cavity. A red, or red and white, patch in the oral cavity (...) painful infectious oral ulcers (of various aetiologies) in an emergency department setting found 2% topical lidocaine was not superior to placebo gel in improving oral fluid intake [ ]. CKS notes that some topical anaesthetic preparations are available over-the-counter, and expert opinion in an AAOM Clinical practice statement states 'topical anaesthetics, anti-inflammatory agents, and analgesics can help reduce the pain of recurrent herpes lesions' [ ], and expert opinion in a US dental review

2016 NICE Clinical Knowledge Summaries

275. Multi-disciplinary Guidelines for the Oral Management of Patients following Oncology Treatment

management recommended is 2% lidocaine mouthwash used prior to eating 62(IIIC) and systemic pain relief with morphine may be used in 21 severe cases. 2.3.8 Prevention of xerostomia: - Parotid function can be partially maintained by radiotherapy delivery that spares the contralateral gland. 69(IIIC) Minimising the dose of radiotherapy to the parotid glands, either by IMRT or 3-dimensional conformal radiotherapy, is encouraged as has been shown to improve xerostomia- related quality of life. 64(IA).70(IIIC

2012 British Society for Disability and Oral Health

276. Hyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Full Text available with Trip Pro

currents in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs).hiPSC-CMs were generated from human skin fibroblasts of a healthy donor. The peak and late sodium currents (INa), steady-state activation, inactivation and recovery from inactivation of INa in hiPSC-CMs were analyzed using the whole-cell patch clamp technique. The effects of different concentrations of the antiarrhythmic drugs flecainide, lidocaine, ajmaline and the antianginal drug ranolazine on INa were tested at 36°C (...) and 40°C. Increasing the temperature of the bath solution from 36°C to 40°C enhanced the inhibition of peak INa but reduced the inhibition of late INa by flecainide and lidocaine. By contrast, increasing the temperature reduced the effect of ajmaline and ranolazine on the peak INa but not late INa. None of the tested drugs showed temperature-dependent effects on the steady-state activation and inactivation as well as on the recovery from inactivation of INa in hiPSC-CMs.Temperature variation from

2016 PLoS ONE

277. Treatment of painful diabetic neuropathy

effect (20%–30% reduction in pain scores from baseline and 70% of patients experienced more than a 30% decrease in pain). e16,e17 Conclusions. Based on Class I and Class II evidence, capsaicin cream is probably effective in lessening the pain of PDN. Based on Class III studies, there is insufficient evidence to determine if IV lidocaine is effective in lessening the pain of PDN. Based on Class III evidence, the Lidoderm patch is possibly effective in lessening the pain of PDN. Based on Class I (...) reviewed include anticonvulsants, antidepressants, opioids, anti-arrhythmics, cannabinoids, aldose reductase inhibitors, protein kinase C beta inhibitors, antioxidants (α-lipoic acid), transketolase activators (thiamines and allithiamines), topical medications (analgesic patches, anesthetic patches, capsaicin cream, clonidine), and others. The nonpharmacologic modalities include infrared therapy, shoe magnets, exercise, acupuncture, external stimulation (transcutaneous electrical nerve stimulation

2011 American Academy of Neurology

278. Supportive care in multiple myeloma

(buccal, sublingual, nasal), TD, IV, Sp 12 μg/h TD patch over 72 h Reduced sedation, emesis, constipation cf morphine; Convenience of 3 d patch TM applications very short‐acting (1–2 h) – best reserved for incident (movement‐related) pains and dressing changes, etc.; Probably immunoneutral Safe in renal failure (Alternative for parenteral use is alfentanil) Safe Use rapid acting TM formulations with caution in patients with addictive tendencies; Affected by CYP3A4‐acting drugs Buprenorphine Partial (...) MOR, ORL1 agonist; KOR, DOR antagonist TM (sublingual), TD, IV 20 μg/h TD patch over 7 d Reduced respiratory depression; Convenience of patches (5–20 μg dose TD patches can last 7 d Nausea with initiation of higher dose TD patch; TM tablet causes nausea Safe Safe Ceiling dose for respiratory depression makes it safer for COPD patients; Does not reverse other MOR opioids at therapeutic doses Diamorphine MOR agonist IV, SC 10 mg SC, IV Familiarity; High water solubility As for morphine Do not use

2011 British Committee for Standards in Haematology

279. Summary of General Palliative Care Guidelines for the Management of Pain at the End of Life for Adults

or an anticonvulsant • Tricyclic Antidepressants e.g. amitriptyline 10mg nocte and increase gradually every 5-7 days to a maximum of 75mg nocte. Caution: known cardiac disease. • Anticonvulsants e.g. Pregabalin (starting dose 25-75mg Bd), or Gabapentin (starting dose 100mg tdS) SECOND LINE – combine a tricyclic antidepressant and anticonvulsant. Also consider • Lidocaine 5% patches applied 12hrly over the area of maximal pain • Capsaicin applied topically to painful area • Corticosteroids –e.g. dexamethasone 8mg (...) /6 of 24 hour morphine dose SeCond line StronG oPioidS • ORAL e.g oxycodone, hydromorphone, • TRANSDERMAL e.g fentanyl Patch * See over • PARENTERAL - e.g. oxycodone, alfentanil , fentanyl, hydromorphone Note: Avoid Cyclimorph® (cyclizine/morphine)injection in end of life care Breakthrough (PRN) analgesia in addition to regular strong opioids patients should have access to breakthrough analgesia- traditionally approximately 1/6 (one sixth) of the total daily dose. for management of incident

2011 Regulation and Quality Improvement Authority

280. General Palliative Care Guidelines for the Management of Pain at the End of Life in Adult Patients

he Cochrane library Issue 2, Chichester; john w iley. nb this review has been withdrawn!! 65 s iddall P, Cousins M, o tte a, g reising t, Chambers r , Murphy t (2006) “Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlles trial” Neurology, 67,10,1792-800 66 Meier t, w asner g , Faust M, kuntzer t, o chsner F, h ueppe M et al (2003) “efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomised, double-blind (...) should be titrated to the need of the individual patient. • Review regularly • Ensure regular laxatives are prescribed with strong opioids. • All patients should have access to antiemetics when opioids are prescribed. • Do not prescribe two paracetamol – containing products at the same time. • Transdermal opioid patches should only be used for stable pain. • Patients receiving a NSAID who are at risk of gastrointestinal side effects should be prescribed appropriate gastric protection. STEP 2: Pain

2011 Regulation and Quality Improvement Authority

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>